Two of the women mistakenly thought they were participating in a clinical trial, as the procedure was advertised on a government-run clinical trial website.

Scott Gottlieb, nominated to lead the U.S. Food and Drug Administration has deep ties to industry, and has worn many other hats in his career.

Telehealth services may boost access to care, but they don’t save money, according to a new study.

Scientists recognize women’s contributions, ‘autism’ can be a strike against a person awaiting organ transplant, and stunning science snapshots show cells, squid and sections of the brain.

Building on weeks of mounting pressure to address high prescription drug prices, three influential U.S. senators have asked the government’s accountability arm to probe the orphan drug program for potential misuse.

At least 83 percent of the United States’ largest patient advocacy groups take contributions from the drug industry, and not all of them are transparent about it.

The findings of a new analysis hint that a 2009 state law establishing the right to a medical interpreter is either not being fully enforced or is not being promoted widely enough.

British scientists anxiously await their country’s departure from the European Union, President Trump’s views on vaccines may fuel a dangerous movement, and an ethicist helps keep gene-editing research in line.

The U.S. medical system depends on doctors from other countries, who often work in areas in desperate need of providers.

Robert Califf, the just-departed commissioner of the U.S. Food and Drug Administration, offers his take on the Trump administration’s plans to speed up drug approvals and dramatically reduce regulations at the agency.